Tris Pharma, Inc. v. Teva Pharmaceuticals USA, Inc.

U.S. Court of Appeals for the Federal Circuit

Tris Pharma, Inc. v. Teva Pharmaceuticals USA, Inc.

Opinion

Case: 23-1158 Document: 5 Page: 1 Filed: 12/14/2022

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

TRIS PHARMA, INC., Plaintiff-Appellee

v.

TEVA PHARMACEUTICALS USA, INC., Defendant-Appellant ______________________

2023-1158 ______________________

Appeal from the United States District Court for the District of New Jersey in No. 2:20-cv-05212-KM-ESK, Judge Kevin McNulty. ______________________

ON MOTION ______________________

ORDER Teva Pharmaceuticals USA, Inc. moves to voluntarily dismiss this appeal pursuant to Rule 42 of the Federal Rules of Appellate Procedure, stating that “[n]o costs are due” and that Tris Pharma, Inc. does not oppose the mo- tion. Mot. at 1. Upon consideration thereof, Case: 23-1158 Document: 5 Page: 2 Filed: 12/14/2022

2 TRIS PHARMA, INC. v. TEVA PHARMACEUTICALS USA, INC.

IT IS ORDERED THAT: (1) The motion is granted. The appeal is dismissed. (2) The parties shall bear their own costs. FOR THE COURT

December 14, 2022 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

ISSUED AS A MANDATE: December 14, 2022

Reference

Status
Unpublished